Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2012
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumorsC Massard, A Kramar, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2009
Why do residents choose the medical oncology specialty? Implications for future recruitment--results of the 2007 French Association of Residents in Oncology (AERIO) SurveyY Loriot, L Albiges-Sauvin, D Dionysopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapyB Besse, C Massard, V Haddad, et al.
British Journal of Cancer|August 19, 2010
A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumoursE Boven, C Massard, J P Armand, et al.
Revue Des Maladies Respiratoires|March 8, 2014
[Management of the cardiovascular complications of treatment in thoracic oncology]S Ederhy, A Hollebecque, N Haddour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2010
Poor prognosis nonseminomatous germ-cell tumours (NSGCTs): should chemotherapy doses be reduced at first cycle to prevent acute respiratory distress syndrome in patients with multiple lung metastases?C Massard, A Plantade, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2013
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)Y Loriot, D Bianchini, E Ileana, et al.
British Journal of Cancer|May 18, 2026
Clinico-molecular predictors of durable response to immune checkpoint inhibitors (ICI) in metastatic cervical cancer (mCC)S Barraud, C Roussel-Simonin, P Pautier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2007
Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave RoussyA Italiano, C Massard, R Bahleda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2010
Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancerS Rajpar, C Massard, A Laplanche, et al.
Pageof 9